General Information of the Compound
Compound ID
CP0472504
Compound Name
N-[5-[benzyl(methyl)sulfamoyl]-3-carbamoylthiophen-2-yl]-1H-pyrazole-5-carboxamide
    Show/Hide
Structure
Formula
C17H17N5O4S2
Molecular Weight
419.488
Canonical SMILES
CN(Cc1ccccc1)S(=O)(=O)c1cc(C(N)=O)c(NC(=O)c2ccn[nH]2)s1
    Show/Hide
InChI
InChI=1S/C17H17N5O4S2/c1-22(10-11-5-3-2-4-6-11)28(25,26)14-9-12(15(18)23)17(27-14)20-16(24)13-7-8-19-21-13/h2-9H,10H2,1H3,(H2,18,23)(H,19,21)(H,20,24)
    Show/Hide
InChIKey
XQLRKFUMNTYTAA-UHFFFAOYSA-N
Physicochemical Property
logP
1.6431
Rotatable Bonds
7
Heavy Atom Count
28
Polar Areas
138.25
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
6
Complexity
28

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 117717678
ChEMBL ID
CHEMBL4790007
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02042, Cystic fibrosis transmembrane conductance regulator
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000535 CFBE41o- Homo sapiens (Human)  1
1
EC50 = 17 nM
   TI
   LI
   LO
   TS